28 related articles for article (PubMed ID: 17598453)
1. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy.
Titmarsh HF; O'Connor R; Dhaliwal K; Akram AR
Front Oncol; 2020; 10():54. PubMed ID: 32117721
[TBL] [Abstract][Full Text] [Related]
3. Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations.
Yilmaz A; Mohamed N; Patterson KA; Tang Y; Shilo K; Villalona-Calero MA; Davis ME; Zhou X; Frankel W; Otterson GA; Beall HD; Zhao W
Int J Environ Res Public Health; 2014 Sep; 11(9):9491-502. PubMed ID: 25222473
[TBL] [Abstract][Full Text] [Related]
4. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
5. [Suppression of WIFI transcript and protein in non-small cell lung carcinomas].
Korobko EV; Kalinichenko SV; Shepelev MV; Zborovskaia IB; Allakhverdiev AK; Zinov'eva MV; Vinogradova TV; Sverdlov ED; Korobko IV
Mol Gen Mikrobiol Virusol; 2007; (2):13-8. PubMed ID: 17598452
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer.
Tsao MS; Yang Y; Marcus A; Liu N; Mou L
Hum Pathol; 2001 Jan; 32(1):57-65. PubMed ID: 11172296
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
[TBL] [Abstract][Full Text] [Related]
8. HMGA2 overexpression in non-small cell lung cancer.
Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
[TBL] [Abstract][Full Text] [Related]
9. [c-Met and HGF expression in non-small-cell lung carcinomas].
Korobko IV; Zinov'eva MV; Allakhverdiev AK; Zborovskaia IB; Svwrdlov ED
Mol Gen Mikrobiol Virusol; 2007; (2):18-21. PubMed ID: 17598453
[TBL] [Abstract][Full Text] [Related]
10. MET as a possible target for non-small-cell lung cancer.
Sadiq AA; Salgia R
J Clin Oncol; 2013 Mar; 31(8):1089-96. PubMed ID: 23401458
[TBL] [Abstract][Full Text] [Related]
11. MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer.
Pérez-Ramírez C; Cañadas-Garre M; Molina MÁ; Faus-Dáder MJ; Calleja-Hernández MÁ
Pharmacol Res; 2015 Dec; 102():90-106. PubMed ID: 26413995
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]